Bolt Biotherapeutics, Inc. Quarterly Return On Assets in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Bolt Biotherapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q3 2024.
  • Bolt Biotherapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -48.6 %, a 36.2% decline year-over-year.
  • Bolt Biotherapeutics, Inc. annual Return On Assets for 2023 was -37.8 %, a 9.06% decline from 2022.
  • Bolt Biotherapeutics, Inc. annual Return On Assets for 2022 was -34.7 %, a 15.4% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -48.6 -12.9 -36.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -44 -8.65 -24.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -37.7 -3.05 -8.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -37.8 -3.14 -9.06% Oct 1, 2023 Dec 31, 2023
Q3 2023 -35.6 -0.89 -2.56% Jul 1, 2023 Sep 30, 2023
Q2 2023 -35.3 -2.57 -7.85% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34.7 -3.87 -12.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -34.7 -4.64 -15.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -34.8 +4.21 +10.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -32.7 Apr 1, 2022 Jun 30, 2022
Q1 2022 -30.8 Jan 1, 2022 Mar 31, 2022
Q4 2021 -30 Oct 1, 2021 Dec 31, 2021
Q3 2021 -39 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.